000 01631 a2200433 4500
005 20250516091413.0
264 0 _c20130329
008 201303s 0 0 eng d
022 _a1569-8041
024 7 _a10.1093/annonc/mds078
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMorris, M J
245 0 0 _aA phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer.
_h[electronic resource]
260 _bAnnals of oncology : official journal of the European Society for Medical Oncology
_cOct 2012
300 _a2714-2719 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAntibodies, Monoclonal
_ximmunology
650 0 4 _aAntigens, Neoplasm
_ximmunology
650 0 4 _aGPI-Linked Proteins
_ximmunology
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNeoplasm Proteins
_ximmunology
650 0 4 _aNeoplastic Cells, Circulating
650 0 4 _aOrchiectomy
650 0 4 _aProstatic Neoplasms
_xtherapy
700 1 _aEisenberger, M A
700 1 _aPili, R
700 1 _aDenmeade, S R
700 1 _aRathkopf, D
700 1 _aSlovin, S F
700 1 _aFarrelly, J
700 1 _aChudow, J J
700 1 _aVincent, M
700 1 _aScher, H I
700 1 _aCarducci, M A
773 0 _tAnnals of oncology : official journal of the European Society for Medical Oncology
_gvol. 23
_gno. 10
_gp. 2714-2719
856 4 0 _uhttps://doi.org/10.1093/annonc/mds078
_zAvailable from publisher's website
999 _c21750106
_d21750106